D. Golshayan

Discipline

Psychologie (3) Economies et finances (2) Sociologie (1) Education (1)

Type de document

Articles (38) Recensions (9)

Co-auteur

Date

Source

Mot-clé

Treatment (20) Transplantation (20) Patients (18) Patients (18) Human beings (15) temps (durée) (13) survie (13) Time (13) Survival (13) Management (13) cohorte (13) risque (12) Swiss (12) Risk (12) Therapeutics (11) Cells (11) maladie (11) thérapie (10) effet (10) maladie (10) puits (9) tissu (corporel) (9) Mice (9) Diseases (9) adulte (8) Transplantation of organs, tissues, etc (8) adulte (8) gestion (7) Development (7) Organ (Musical instrument) (7)

Documents écrit par D. Golshayan (38) | parle de D. Golshayan (0)

Clinical prediction model for prognosis in kidney transplant recipients (KIDMO): study protocol.
S. Schwab et al. (7 mars 2023)
Incidence, Risk Factors, and Management of Incisional Hernias After Kidney Transplant: A 20-Year Single Center Experience.
L. Costa et al.
Donation type and the effect of pre-transplant donor specific antibodies - Data from the Swiss Transplant Cohort Study.
O. de Rougemont et al. (2023)
The Rational Use of Complement Inhibitors in Kidney Diseases.
F. Fakhouri et al.
Recurrence of IgA nephropathy after kidney transplantation: experience from the Swiss transplant cohort study.
C. Jäger et al. (10 mai 2022)
Hypertension après transplantation rénale [Hypertension after kidney transplantation]
N. Schwotzer et al. (15 sept. 2021)
Impact of Hyponatremia after Renal Transplantation on Decline of Renal Function, Graft Loss and Patient Survival: A Prospective Cohort Study.
L. Berchtold et al. (27 août 2021)
Mutually exclusive lymphangiogenesis or perineural infiltration in human skin squamous-cell carcinoma.
J. Schaller et al. (30 mars 2021)
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study.
N. Perrottet et al. (2021)
Age at Time of Kidney Transplantation as a Predictor for Mortality, Graft Loss and Self-Rated Health Status: Results From the Swiss Transplant Cohort Study.
N. Beerli et al. (2021)
SARS-CoV-2 / COVID-19 in patients on the Swiss national transplant waiting list.
C. Benden et al. (14 déc. 2020)
Immunosuppression management in renal transplant recipients with normal-immunological risk: 10-year results from the Swiss Transplant Cohort Study.
A. Krisl et al. (30 nov. 2020)
Upfront use of eculizumab to treat early acute antibody-mediated rejection after kidney allotransplantation and relevance for xenotransplantation.
N. Schwotzer et al.
Diabète post-transplantation rénale: le point de vue du diabétologue [Post-transplantation diabetes in kidney transplant: from the diabetologist point of view]
A. Pauchet et al. (10 juin 2020)
Infection à SARS-CoV-2 et transplantation d’organes solides [SARS-CoV-2 infection and solid organ transplantation]
D. Golshayan et al. (29 avr. 2020)
Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.
L. Govender et al. (2020)
Differential Effects of the Mitochondria-Active Tetrapeptide SS-31 (D-Arg-dimethylTyr-Lys-Phe-NH2) and Its Peptidase-Targeted Prodrugs in Experimental Acute Kidney Injury.
J.C. Wyss et al. (2019)
Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients.
L. Quteineh et al.
Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction.
L. Juillerat-Jeanneret et al. (21 nov. 2018)
Targeted γ-secretase inhibition of Notch signaling activation in acute renal injury.
J.C. Wyss et al. (1 mai 2018)
Rituximab as monotherapy for the treatment of chronic active antibody-mediated rejection after kidney transplantation.
Y.D. Muller et al.
Fibroblast activation protein-α in fibrogenic disorders and cancer: more than a prolyl-specific peptidase?
L. Juillerat-Jeanneret et al.
Update on Dendritic Cell-Induced Immunological and Clinical Tolerance.
C. Obregon et al. (2017)
IL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154-CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized Mice.
L. Govender et al. (2017)
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.
L. Quteineh et al.

next